Clinical Study Results
Research Sponsor: AstraZeneca AB
Drug Studied: Acalabrutinib
Study Title: A study to learn more about how acalabrutinib
acts in the blood in healthy participants
when taken different ways
Protocol Number: D822FC00004
Thank you!
Thank you to the participants who took part in the clinical study for the study drug
acalabrutinib. AstraZeneca AB sponsored this study and thinks it is important to
share the results. An independent non-profit organization called CISCRP helped
prepare this summary of the study results.
If you participated in the study and have questions about the results, please speak
with the study doctor or staff at your study site.
1